eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2001
vol. 5
 
Share:
Share:
abstract:

Thalidomide in the treatment of multiple myeloma

Małgorzata Rokicka-Piotrowicz

Współcz Onkol (2001) vol. 5, 4, 161-164
Online publish date: 2003/07/16
View full text Get citation
 
More than three decades after its withdrawal from the world market thalidomide is attracting growing interest because of its reported antiangiogenetic, immunomodulatory and anti-inflammatory properties. Recently, the drug was approved for sale in the United States for the treatment of erythrema nodosum leprosum. This review presents a new possibility of treatment of multiple myeloma patients with thalidomide. The dosage and side effects of thalidomide are described.
keywords:

multiple myeloma, thalidomide, cancer treatment

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.